CINECA IRIS Institutional Research Information System

VITTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 39.975
EU - Europa 23.498
AS - Asia 16.908
SA - Sud America 2.351
AF - Africa 798
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 16
Totale 83.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.588
IT - Italia 10.731
SG - Singapore 5.071
CN - Cina 4.816
CA - Canada 3.140
HK - Hong Kong 2.731
SE - Svezia 2.490
FI - Finlandia 2.393
DE - Germania 2.279
BR - Brasile 1.927
VN - Vietnam 1.469
BG - Bulgaria 1.175
GB - Regno Unito 940
TR - Turchia 837
FR - Francia 790
RU - Federazione Russa 543
NL - Olanda 476
UA - Ucraina 468
AT - Austria 422
IN - India 409
KR - Corea 314
CI - Costa d'Avorio 287
JP - Giappone 264
BD - Bangladesh 179
CH - Svizzera 166
SN - Senegal 147
AR - Argentina 129
MX - Messico 123
PK - Pakistan 114
IQ - Iraq 105
PL - Polonia 105
BE - Belgio 96
ZA - Sudafrica 93
ID - Indonesia 78
ES - Italia 77
SA - Arabia Saudita 72
IE - Irlanda 68
EC - Ecuador 64
UZ - Uzbekistan 56
VE - Venezuela 55
MY - Malesia 53
GR - Grecia 52
NG - Nigeria 46
AU - Australia 43
MA - Marocco 43
PY - Paraguay 42
CO - Colombia 40
RO - Romania 36
PH - Filippine 34
KE - Kenya 33
CL - Cile 32
IR - Iran 30
UY - Uruguay 30
EG - Egitto 29
IL - Israele 27
JO - Giordania 26
LT - Lituania 25
LV - Lettonia 25
DZ - Algeria 24
CZ - Repubblica Ceca 23
CR - Costa Rica 22
NP - Nepal 21
KZ - Kazakistan 20
PE - Perù 20
OM - Oman 19
TN - Tunisia 19
AE - Emirati Arabi Uniti 18
TH - Thailandia 18
TT - Trinidad e Tobago 18
AZ - Azerbaigian 17
AL - Albania 15
BJ - Benin 15
HU - Ungheria 15
JM - Giamaica 15
PA - Panama 15
PS - Palestinian Territory 15
TW - Taiwan 15
EE - Estonia 14
ET - Etiopia 13
ZM - Zambia 13
DK - Danimarca 11
EU - Europa 11
LB - Libano 10
LY - Libia 10
NZ - Nuova Zelanda 10
GT - Guatemala 9
KG - Kirghizistan 9
NO - Norvegia 9
RS - Serbia 9
SY - Repubblica araba siriana 9
BH - Bahrain 8
BO - Bolivia 8
GE - Georgia 8
HR - Croazia 8
DO - Repubblica Dominicana 7
SM - San Marino 7
BB - Barbados 6
HN - Honduras 6
PT - Portogallo 6
CY - Cipro 5
Totale 83.483
Salva come PNG Salva come JPEG
Città #
Ashburn 4.021
Woodbridge 3.405
Fairfield 3.264
Singapore 2.852
Hong Kong 2.676
Ann Arbor 2.471
Houston 2.430
Montreal 2.361
Chandler 2.144
Helsinki 1.968
San Jose 1.691
Santa Clara 1.641
Dallas 1.640
Milan 1.497
Seattle 1.365
Wilmington 1.202
Sofia 1.169
Cambridge 1.057
Beijing 1.019
Shanghai 1.001
New York 819
Ottawa 634
Rome 581
Boardman 509
Princeton 509
Serra 477
Los Angeles 468
Jacksonville 454
Izmir 448
Lawrence 447
Hefei 409
Medford 399
Lauterbourg 395
Vienna 370
Ho Chi Minh City 369
Florence 355
Nanjing 339
Des Moines 331
Seoul 292
Abidjan 286
Hanoi 267
Munich 262
Istanbul 243
Tokyo 219
Dearborn 202
Frankfurt am Main 202
Pisa 184
Buffalo 173
São Paulo 171
Naples 170
Dong Ket 169
London 164
Redondo Beach 162
Council Bluffs 157
Boulder 155
San Diego 154
Dakar 147
Columbus 141
The Dalles 139
Bologna 125
Redwood City 122
Falls Church 119
Nanchang 118
Bern 116
Bremen 114
Bari 107
Palermo 102
Jüchen 100
Menlo Park 98
Lancaster 94
Ogden 93
Turin 87
Brussels 85
Kunming 82
Shenyang 81
Guangzhou 74
Hebei 74
Marseille 74
Catania 73
Düsseldorf 72
Orem 72
Fuzhou 71
Changsha 66
Tianjin 66
Turku 65
Chicago 64
Brescia 63
Washington 62
Phoenix 61
Rio de Janeiro 59
Detroit 57
Jiaxing 56
Amsterdam 53
Lahore 51
Tashkent 51
Brooklyn 50
Jinan 50
Padova 49
Paris 49
Belo Horizonte 48
Totale 56.419
Salva come PNG Salva come JPEG
Nome #
Tiroidite cronica autoimmune 12.570
Ontogenetic development of pancreatic thyrotropin-releasing hormone in human foetuses and in infants. 356
The role of nuclear medicine in the clinical management of benign thyroid disorders. Part 1. Hyperthyroidism 341
Gozzo diffuso tossico (morbo di Flajani-Basedow-Graves) e tiroidite cronica autoimmune, Inquadramento nosologico e terapia medica 293
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 275
Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome 270
Natural history of graves’ orbitopathy after treatment 265
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 253
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 253
Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women. 253
Leonardo da Vinci "Design of Lady with Graves' disease" (1452-1519) 252
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 252
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 243
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 243
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 243
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 241
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 239
Sera of patients with idiopathic myxedema contain IgG which block TSH-stimulated thyroid adenylate cyclase 237
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 235
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 234
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 233
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 233
Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules. 231
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding 229
Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotropin. 222
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 222
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 219
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 219
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER 219
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 218
Effects Of Long-term Tamoxifen Therapy On The Course Of Chronic Autoimmune Thyroiditis 218
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 217
Molecular interactions at the cell surface: role of glycoconjugates and membrane lipids in receptor recognition processes. 216
uptake of amiodarone by thyroidal and non-thyroidal cell lines 215
In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity 215
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 215
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 214
Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. 213
Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. 213
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 211
Thyroid autoimmunity, thyroglobulin autoantibodies and thyroid cancer prognosis 210
Results of Vardenafil Mediated Power Doppler Ultrasound, Contrast Enhanced Ultrasound and Systematic Random Biopsies to Detect Prostate Cancer 210
Thyrotropin stimulation of the ADP-ribosyltransferase activity of bovine thyroid membranes. 207
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 207
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 207
A study on the relationship between intraglandular arterial distribution and thyroid lobe shape: implications for biotechnology of a bioartificial thyroid 206
Thyroid-stimulating antibody mimics thyrotropin in its ability to desensitize the adenosine 3',5'-monophosphate response to acute stimulation in continuously cultured rat thyroid cells (FRT-L5). 205
Effects of bariatric surgery on preclinical myocardial alterations in severe obesity 203
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 203
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 203
Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I 203
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 203
Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. 201
Diagnosis of thyroid dysfunction: present and future. 201
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 201
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. 200
STUDY OF POTENTIAL INHIBITORS OF THYROID IODIDE UPTAKE BY USING CHO CELLS STABLY EXPRESSING THE HUMAN SODIUM/IODIDE SYMPORTER (hNIS) PROTEIN 200
Causes and laboratory investigations of thyrotoxicosis 200
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma 200
Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women 199
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts 199
Interference of serum thyroglobulin in the radioassay for serum antithyroglobulin antibodies. 198
[Thyroid-stimulating immunoglobulins. The related antigens] 197
Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules 197
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center 197
Graves' Disease Induced by Immune Checkpoint Inhibitors: A case report and Review of the literature 197
mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study 196
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 196
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 196
Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay. 194
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 193
Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin 193
DIAGNOSTIC AND THERAPEUTIC ROLE OF THYROID REMNANT ABLATION WITH LOW ACTIVITY OF 131I IN PATIENTS WITH LOW AND INTERMEDIATE RISK PAPILLARY THYROID CARCINOMA (PTC). 191
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study 191
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 190
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 190
Electric and magnetic fields do not modify the biochemical properties of FRTL-5 cells 190
Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma 190
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 190
The expression of platelet serotonin transporter (SERT) in human obesity 189
Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato 189
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease 187
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) 187
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 187
Thyroglobulin Autoantibodies arise before Thyroperoxidase Autoantibodies in Juvenile Autoimmune Thyroiditis 187
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 186
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 186
Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease. 186
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 186
TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells 186
Percutaneous ethanol injection: what is its role in the management of nodular lesions of endocrine glands? 185
Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up of juvenile Graves disease 185
Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter 185
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 185
ROLE OF THYROID REMNANT ABLATION WITH LOW ACTIVITY OF 131I IN PATIENTS WITH LOW AND INTERMEDIATE RISK PAPILLARY THYROID CARCINOMA (PTC). 184
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 184
Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype 184
Thyroid volume in children: role of iodine intake. 183
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 183
Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. 182
Totale 33.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 210.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021585 0 0 0 0 0 0 0 0 0 0 0 585
2021/20225.828 112 234 135 381 1.188 831 173 268 464 364 239 1.439
2022/20237.857 848 940 574 644 813 909 173 604 1.313 168 637 234
2023/20249.104 736 621 683 438 802 1.003 374 539 246 2.615 394 653
2024/202516.049 293 714 399 1.106 1.491 1.462 1.241 978 1.669 2.133 1.616 2.947
2025/202618.085 1.224 2.027 1.877 1.517 1.650 1.376 2.617 790 2.775 1.426 638 168
Totale 84.433